Park Sung Wook, Choi Kyong, Lee Hwanghee Blaise, Park Sung Kwang, Turner Anthony J, Hooper Nigel M, Park Haeng Soon
College of Pharmacy, Hormone Research Center, Chonnam National University, Kwangju, Korea.
Kidney Blood Press Res. 2002;25(1):7-12. doi: 10.1159/000049429.
The release mechanism of the glycosyl-phosphatidylinositol (GPI)-anchored renal dipeptidase (EC 3.4.13.19) in vivo has been investigated. Triton X-114 phase separation indicated that the dipeptidase is exclusively present as a hydrophilic form in urine from porcine, rat, rabbit and human. Western blot analysis of human and porcine purified dipeptidase and the urine concentrates with anti-(cross-reacting determinant) serum demonstrated the presence of inositol 1,2-cyclic monophosphate indicating that the renal dipeptidase had been released from the membrane by the action of a phospholipase C. This is the first direct evidence for cleavage of a human GPI-anchored protein by a responsible phospholipase C in vivo.
已对糖基磷脂酰肌醇(GPI)锚定的肾二肽酶(EC 3.4.13.19)在体内的释放机制进行了研究。Triton X-114相分离表明,该二肽酶在猪、大鼠、兔和人的尿液中仅以亲水形式存在。用人和猪纯化的二肽酶以及尿液浓缩物与抗(交叉反应决定簇)血清进行蛋白质印迹分析,结果表明存在肌醇1,2-环单磷酸,这表明肾二肽酶已通过磷脂酶C的作用从膜上释放出来。这是体内一种有活性的磷脂酶C切割人GPI锚定蛋白的首个直接证据。